Clinical trial approval / initiation

Explore the landscape of Clinical trial approval / initiation in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on Clinical trial approval / initiation to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Northland Biotech's Sedominji Completes First National Shipment – World's First Approved HGF Naked Plasmid Gene Therapy Reaches CLI Patients in Nine Provinces
CompanyDrug

Northland Biotech’s Sedominji Completes First National Shipment – World’s First Approved HGF Naked Plasmid Gene Therapy Reaches CLI Patients in Nine Provinces

Beijing Northland Biotechnology Co., Ltd. announced that its independently developed Class 1 innovative gene therapy, Sedominji Injection (brand name: Huasuoling®), completed its first nationwide shipment at the production base of…

GeneScience's GenSci161 Wins NMPA Acceptance for Recurrent Pericarditis Clinical Trial – Novel Fully Human IL‑1α/IL‑1β Bispecific Antibody

GeneScience’s GenSci161 Wins NMPA Acceptance for Recurrent Pericarditis Clinical Trial – Novel Fully Human IL‑1α/IL‑1β Bispecific Antibody

Youcare Pharmaceutical's YKYY036 Wins Dual Clinical Clearances from NMPA and FDA – GalNAc‑Conjugated siRNA Targeting INHBE Advances Global Obesity Program

Youcare Pharmaceutical’s YKYY036 Wins Dual Clinical Clearances from NMPA and FDA – GalNAc‑Conjugated siRNA Targeting INHBE Advances Global Obesity Program

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDrug

Grand Pharma’s TLX591-CDx Approved for Prostate Cancer Diagnosis in China

CompanyDrug

Genor Biopharma Initiates First Patient Dosing for GB263T in China

CompanyDrug

Akeso Biopharma Gains NMPA Approval for AK112 and AK119 Clinical Study

CompanyDrug

Kira Pharmaceuticals Gains NMPA Approval for Phase II Study of KP104 in PNH

CompanyDrug

NMPA Approves IND Filing for Henan Genuine Biotech’s Long-Acting HIV Drug CL-197

CompanyDrug

Simcere Completes Enrollment for Phase III Study of CDK4/6 Inhibitor in mTNBC

CompanyDrug

Fujian Cosunter Doses First Patient in Phase I Study of COVID-19 Drug GST-HG171

CompanyDrug

Ascletis Pharma Doses First Patient in Phase II Study of ASC41 for NASH

Show More